Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant

Leukemia and Lymphoma

Volumn 58, Issue 1, 2017, Pages 233-236

  Mason, Emily F ^a   Brown, Ronald D ^a   Szeto, David P ^a   Gibson, Christopher J ^b   Jia, Yonghui ^a   Garcia, Elizabeth P ^a   Jacobson, Caron A ^b   Dal Cin, Paola ^a   Kuo, Frank C ^a   Pinkus, Geraldine S ^a   Lindeman, Neal I ^a   Sholl, Lynette M ^a   Aster, Jon C ^a   Morgan, Elizabeth A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN LAMBDA CHAIN; MAP2K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;

ADULT; ANEMIA; BONE MARROW BIOPSY; CASE REPORT; DYSPNEA; FOLLOW UP; GAIN OF FUNCTION MUTATION; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIATION; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; LETTER; LEUKOCYTE COUNT; MALE; MAP2K1 GENE; MIDDLE AGED; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PYROSEQUENCING; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA; GENETICS; HIGH THROUGHPUT SEQUENCING; LITERATURE; PATHOLOGY; PROCEDURES;

HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MAP KINASE KINASE 1; MIDDLE AGED; MUTATION, MISSENSE; REVIEW LITERATURE AS TOPIC;

EID: 84973092326     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428194.2016.1185786     Document Type: Letter

References (15)

1. E.Tiacci, V.Trifonov, G.Schiavoni,. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305–2315.
2. R.J.Kreitman Hairy cell leukemia-new genes, new targets. Curr Hematol Malig Rep. 2013;8:184–195.
3. J.J.Waterfall, E.Arons, R.L.Walker,. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46:8–10.
4. N.A.Brown, L.V.Furtado, B.L.Betz,. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative langerhans cell histiocytosis. Blood. 2014;124:1655–1658.
5. D.Rossi, V.Trifonov, M.Fangazio,. The coding genome of splenic marginal zone lymphoma:Activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209:1537–1551.
6. D.Martinez, A.Navarro, A.Martinez-Trillos,. NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease. Am J Surg Pathol. 2016;40:192–201.
7. L.A.Doyle, K.K.Wong, R.Bueno,. Ewing sarcoma mimicking atypical carcinoid tumor:detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool. Cancer Genet. 2014;207:335–339.
8. J.L.Marks, Y.Gong, D.Chitale,. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma. Cancer Res. 2008;68:5524–5528.
9. L.Xi, E.Arons, W.Navarro,. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119:3330–3332.
10. S.Jaiswal, P.Fontanillas, J.Flannick,. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–2498.
11. N.Wagle, C.Emery, M.F.Berger,. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol. 2011;29:3085–3096.
12. P.Jares, D.Colomer, E.Campo Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122:3416–3423.
13. R.Kridel, B.Meissner, S.Rogic,. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 2012;119:1963–1971.
14. S.Bea, R.Valdes-Mas, A.Navarro,. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA. 2013;110:18250–18255.
15. A.L.Schulz, B.Albrecht, C.Arici,. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and costello syndrome. Clin Genet. 2008;73:62–70.